Effect of Semet (80 and 160 mcg) Versus Placebo in Euthyroid Patients With AIT
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02302768|
Recruitment Status : Unknown
Verified November 2014 by Furio Pacini, University of Siena.
Recruitment status was: Active, not recruiting
First Posted : November 27, 2014
Last Update Posted : November 27, 2014
University of Siena
IBSA Institut Biochimique SA
Information provided by (Responsible Party):
Furio Pacini, University of Siena
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Actual Primary Completion Date :||January 2014|
|Estimated Study Completion Date :||January 2015|
Rayman MP. Selenium and human health. Lancet. 2012 Mar 31;379(9822):1256-68. doi: 10.1016/S0140-6736(11)61452-9. Epub 2012 Feb 29. Review.
Nacamulli D, Petricca D, Mian C. Selenium and autoimmune thyroiditis. J Endocrinol Invest. 2013 Nov;36(10 Suppl):8-14.